Cytotoxic drugs and leukaemogenesis.
D000328:Adult; D000368:Aged; D001151:Arsenic / Q000009:adverse effects; D001554:Benzene / Q000009:adverse effects; D001853:Bone Marrow / Q000187:drug effects; D001943:Breast Neoplasms / Q000139:chemically induced; D005260:Female; D006689:Hodgkin Disease / Q000139:chemically induced; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D007945:Leukemia, Lymphoid / Q000139:chemically induced; D008223:Lymphoma / Q000139:chemically induced; D008297:Male; D008558:Melphalan / Q000009:adverse effects; D008875:Middle Aged; D009101:Multiple Myeloma / Q000139:chemically induced; D009182:Mycosis Fungoides / Q000139:chemically induced; D010051:Ovarian Neoplasms / Q000139:chemically induced; D010265:Paraproteinemias / Q000139:chemically induced; D008258:Waldenstrom Macroglobulinemia / Q000139:chemically induced
D001554:Benzene; D001151:Arsenic; D008558:Melphalan